276 related articles for article (PubMed ID: 22031222)
1. Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study.
McAdams DeMarco MA; Maynard JW; Baer AN; Gelber AC; Young JH; Alonso A; Coresh J
Arthritis Rheum; 2012 Jan; 64(1):121-9. PubMed ID: 22031222
[TBL] [Abstract][Full Text] [Related]
2. A urate gene-by-diuretic interaction and gout risk in participants with hypertension: results from the ARIC study.
McAdams-DeMarco MA; Maynard JW; Baer AN; Kao LW; Kottgen A; Coresh J
Ann Rheum Dis; 2013 May; 72(5):701-6. PubMed ID: 22753387
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis.
Dalbeth N; Phipps-Green A; Frampton C; Neogi T; Taylor WJ; Merriman TR
Ann Rheum Dis; 2018 Jul; 77(7):1048-1052. PubMed ID: 29463518
[TBL] [Abstract][Full Text] [Related]
4. Thiazide diuretics and the initiation of anti-gout therapy.
Gurwitz JH; Kalish SC; Bohn RL; Glynn RJ; Monane M; Mogun H; Avorn J
J Clin Epidemiol; 1997 Aug; 50(8):953-9. PubMed ID: 9291881
[TBL] [Abstract][Full Text] [Related]
5. Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study.
McAdams-DeMarco MA; Maynard JW; Coresh J; Baer AN
Arthritis Res Ther; 2012 Aug; 14(4):R193. PubMed ID: 22906142
[TBL] [Abstract][Full Text] [Related]
6. Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort.
McAdams-DeMarco MA; Maynard JW; Baer AN; Coresh J
J Clin Hypertens (Greenwich); 2012 Oct; 14(10):675-9. PubMed ID: 23031144
[TBL] [Abstract][Full Text] [Related]
7. Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities.
Sun M; Vazquez AI; Reynolds RJ; Singh JA; Reeves M; Merriman TR; Gaffo AL; Los Campos G
Arthritis Res Ther; 2018 May; 20(1):90. PubMed ID: 29720278
[TBL] [Abstract][Full Text] [Related]
8. Do Serum Urate-associated Genetic Variants Influence Gout Risk in People Taking Diuretics? Analysis of the UK Biobank.
Narang RK; Gamble G; Phipps-Green AJ; Topless R; Cadzow M; Stamp LK; Merriman TR; Dalbeth N
J Rheumatol; 2020 Nov; 47(11):1704-1711. PubMed ID: 32007933
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study.
Maynard JW; McAdams-DeMarco MA; Law A; Kao L; Gelber AC; Coresh J; Baer AN
Am J Epidemiol; 2014 Mar; 179(5):576-83. PubMed ID: 24335384
[TBL] [Abstract][Full Text] [Related]
10. Use of diuretics and risk of incident gout: a population-based case-control study.
Bruderer S; Bodmer M; Jick SS; Meier CR
Arthritis Rheumatol; 2014 Jan; 66(1):185-96. PubMed ID: 24449584
[TBL] [Abstract][Full Text] [Related]
11. Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort.
Ranieri L; Contero C; Peral ML; Calabuig I; Zapater P; Andres M
Arthritis Res Ther; 2018 Mar; 20(1):53. PubMed ID: 29566736
[TBL] [Abstract][Full Text] [Related]
12. Serum urate and incidence of kidney disease among veterans with gout.
Krishnan E; Akhras KS; Sharma H; Marynchenko M; Wu E; Tawk RH; Liu J; Shi L
J Rheumatol; 2013 Jul; 40(7):1166-72. PubMed ID: 23678154
[TBL] [Abstract][Full Text] [Related]
13. Gout in Older Adults: The Atherosclerosis Risk in Communities Study.
Burke BT; Köttgen A; Law A; Grams M; Baer AN; Coresh J; McAdams-DeMarco MA
J Gerontol A Biol Sci Med Sci; 2016 Apr; 71(4):536-42. PubMed ID: 26714568
[TBL] [Abstract][Full Text] [Related]
14. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study.
Hunter DJ; York M; Chaisson CE; Woods R; Niu J; Zhang Y
J Rheumatol; 2006 Jul; 33(7):1341-5. PubMed ID: 16758506
[TBL] [Abstract][Full Text] [Related]
15. Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population-Based, Prospective Study and Mendelian Randomization Analysis.
Joshi AD; McCormick N; Yokose C; Yu B; Tin A; Terkeltaub R; Merriman TR; Eliassen AH; Curhan GC; Raffield LM; Choi HK
Arthritis Rheumatol; 2023 Sep; 75(9):1648-1657. PubMed ID: 37043280
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic features of diuretic-associated gout: a case-control study.
Mitnala S; Phipps-Green A; Franklin C; Horne A; Stamp LK; Merriman TR; Dalbeth N
Rheumatology (Oxford); 2016 Jul; 55(7):1172-6. PubMed ID: 26989110
[TBL] [Abstract][Full Text] [Related]
17. Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study.
Roughley M; Sultan AA; Clarson L; Muller S; Whittle R; Belcher J; Mallen CD; Roddy E
Arthritis Res Ther; 2018 Oct; 20(1):243. PubMed ID: 30376864
[TBL] [Abstract][Full Text] [Related]
18. Serum urate association with hypertension in young adults: analysis from the Coronary Artery Risk Development in Young Adults cohort.
Gaffo AL; Jacobs DR; Sijtsma F; Lewis CE; Mikuls TR; Saag KG
Ann Rheum Dis; 2013 Aug; 72(8):1321-7. PubMed ID: 22984170
[TBL] [Abstract][Full Text] [Related]
19. Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study.
Greenberg KI; McAdams-DeMarco MA; Köttgen A; Appel LJ; Coresh J; Grams ME
Clin J Am Soc Nephrol; 2015 May; 10(5):776-83. PubMed ID: 25717072
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.
Drivelegka P; Sigurdardottir V; Svärd A; Jacobsson LTH; Dehlin M
Arthritis Res Ther; 2018 Jun; 20(1):108. PubMed ID: 29855389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
